Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer

K Vyas, M Rathod, MM Patel - Nanomedicine: Nanotechnology, Biology …, 2023 - Elsevier
Oral cancer is a type of cancer that develops in the mouth and is one of the deadliest
malignancies in the world. Currently surgical, radiation therapy, and chemotherapy are most …

The formation and therapeutic update of tumor-associated macrophages in cervical cancer

Q Wang, A Steger, S Mahner, U Jeschke… - International journal of …, 2019 - mdpi.com
Both clinicopathological and experimental studies have suggested that tumor-associated
macrophages (TAMs) play a key role in cervical cancer progression and are associated with …

[PDF][PDF] Recent advances of nano-drug delivery system in oral squamous cell carcinoma treatment.

Y Zhu, LM Wen, R Li, W Dong, SY Jia… - European Review for …, 2019 - europeanreview.org
Oral squamous cell carcinoma (OSCC) is one of the main causes of death in oral diseases.
With the development of nanotechnology, great progress has been made in the diagnosis …

TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment

Z Zhang, X Zhou, J Guo, F Zhang, Y Qian… - Journal of Translational …, 2022 - Springer
As an important component of the immunosuppressive tumor microenvironment (TME), it
has been established that mesenchymal stem cells (MSCs) promote the progression of …

Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies

N Kindt, J Preillon, H Kaltner, HJ Gabius… - Journal of cancer …, 2013 - Springer
Purpose The present in vivo/in vitro study was undertaken in order to evaluate the
importance of macrophage migration inhibitory factor (MIF) in the progression of head and …

[HTML][HTML] LncRNA PTCSC3 suppressed cervical carcinoma cell invasion and proliferation via regulating miR-574-5p

M Zhang, Y Song, L Yu - American journal of translational research, 2019 - ncbi.nlm.nih.gov
LncRNAs have been shown to invovled in the development of various cancers. However,
the function and potential mechanism of PTCSC3 in cervical carcinoma progression remains …

Brain miffed by macrophage migration inhibitory factor

NE Savaskan, G Fingerle-Rowson… - … journal of cell …, 2012 - Wiley Online Library
Macrophage migration inhibitory factor (MIF) is a cytokine which also exhibits enzymatic
properties like oxidoreductase and tautomerase. MIF plays a pivotal role in innate and …

Combined knockdown of D-dopachrome tautomerase and migration inhibitory factor inhibits the proliferation, migration, and invasion in human cervical cancer

Q Wang, Y Wei, J Zhang - International Journal of Gynecologic Cancer, 2017 - ijgc.bmj.com
Objective D-dopachrome tautomerase (D-DT) is a homologue of macrophage migration
inhibitory factor (MIF) with similar functions. However, the possible biological roles of D-DT …

Current novel drug deliveries for oral cancer: A chronotherapeutic approach

KP Sutar, NS Shirkoli, PS Sutar, BK Kurangi… - Current Drug …, 2023 - ingentaconnect.com
Oral squamous cell carcinoma is a malignant disease that is causing considerable mortality
worldwide. Conventional treatment approaches, like surgery, cause destructive alterations in …

[HTML][HTML] KSHV co-infection, a new co-factor for HPV-related cervical carcinogenesis?

L Dai, M Zhao, W Jiang, Z Lin… - American journal of …, 2018 - ncbi.nlm.nih.gov
High-risk human papillomavirus (HPV) infection is the etiological agent of cervical cancer
and some other cancers. Kaposi sarcoma-associated herpesvirus (KSHV) represents a …